Gut Microbes 5 (4), 533540
A study reported that there was no difference in post-prandial plasma incretin concentrations between diffuse and focal cases, and no difference in baseline plasma incretin concentration between focal, diffuse, and transient hyperinsulinism ( Studies in a mouse model of K ATP hyperinsulinism, the most common and severe genetic subtype of hyperinsulinism, have shown that the GLP-1 receptor antagonist exendin-(9-39) significantly increases fasting plasma glucose and decreases the insulin to glucose ratio on the fasting state, effectively reversing the hyperinsulinemic hypoglycemia phenotype
Indeed, GLP-1RA therapy appears to be well tolerated overall, and proportions of clinical trial participants discontinuing treatment because of adverse events tend to be low (5.49.9%) [10, 37, 39, 43, 46, 47]
As research into compounds like 5-Amino-1MQ evolves, interpretations may change as new data becomes available
The information on this page is provided for educational and informational purposes only & is not intended to replace professional medical advice, diagnosis, or treatment
We calculated the remaining excess risk associated with prediabetes not explained by progression to diabetes using the following equation: 1 (HR prediabetes HR prediabetes allowing progression to diabetes ) / (HR prediabetes 1)
